I'll replace MITI with MACK, PCYC with ARQL. I still like Ibutinib a lot, have to take profit after big run like that. Here is updated list:
1. Generic/biosimilar/biobetter: PLX, MNTA
2. Small molecule kinase inhibitor: ARRY, ARQL, EXEL
3. Antibody conjugate: IMGN, SGEN, CLDX
4. Drug delivery: NKTR, HALO, ALKS
5. Bi- or Multi-Specific Antibody: MACK
6. Antibiotic: TSRX
7. Established small/mid cap: BMRN, ONXX